北京将建网络号贩子黑名单,执法部门挂号平台医疗机构共享

2018-01-19 张小妹 北京青年报

记者从市卫计委获悉,本市今年将建立执法部门—挂号平台—医疗机构三方共享的“网络号贩子”黑名单制度,努力实现对号贩子的联合惩戒。日前,市卫计委联合市公安局召开打击“网络号贩子”座谈会。北青报记者从座谈会上获悉,针对“网络号贩子”隐蔽性强、违法成本低、犯罪取证难的特点,2018年本市将建立执法部门—挂号平台—医疗机构三方共享的“网络号贩子”黑名单制度,努力实现对号贩子的联合惩戒。据悉,目前北京妇产医院

记者从市卫计委获悉,本市今年将建立执法部门—挂号平台—医疗机构三方共享的“网络号贩子”黑名单制度,努力实现对号贩子的联合惩戒。

日前,市卫计委联合市公安局召开打击“网络号贩子”座谈会。北青报记者从座谈会上获悉,针对“网络号贩子”隐蔽性强、违法成本低、犯罪取证难的特点,2018年本市将建立执法部门—挂号平台—医疗机构三方共享的“网络号贩子”黑名单制度,努力实现对号贩子的联合惩戒。

据悉,目前北京妇产医院已与京医通挂号平台、驻院民警进行“黑名单”联动。如果医务人员或门诊部发现有患者退号后再挂号情况,及时查询退号者信息,对高度怀疑号贩子的卡号,在京医通平台加入“黑名单”。同时与驻院民警联动,对收集的已掌握的号贩子信息,通过京医通平台查询,对反复挂号退号、无就诊记录的就诊卡号加入“黑名单”。

市卫计委相关负责人指出,接下来医疗机构和相关挂号平台要严格执行实名挂号和实名就诊制度,积极探索挂号平台网络预约经费结算方式,统一网络号源开放时间,加大信息监管。同时,要加强挂号平台和医疗机构内部管理,进一步做好技术防范和人力防范工作,压缩各种“号贩子”的生存空间。

座谈会上,多家三甲医院分享了“防号贩子”经验方法。北京妇产医院相关负责人介绍,由于114平台产科挂号时无法识别患者身份的真实性,且预约周期长达8周,与产科初诊病人的实际需求不符。为此,北京妇产医院从今年1月1日起,收回114平台产科号源,改投到京医通平台。

北京儿童医院相关负责人介绍,医院系统已经和公安系统专线对接,可以识别身份证真伪,每一位监护人身份证号最多可办三张就诊卡。同时,儿童医院将对连续多日挂不同紧俏热门号源及同一天挂多个紧俏热门号源的账号进行跟踪。

市公安局在座谈会上介绍,2017年1月至12月,本市共打击处理号贩子892人。近两年来,公安机关打掉“号贩子”团伙7个,抓获违法犯罪人员101人,其中刑事拘留17人,治安拘留37人。

北青报记者了解到,在公安机关严厉打击的同时,各级各类医疗卫生机构也不断加大对“号贩子”的清理力度。2017年,仅北京大学第三医院就清理“号贩子”3629人次,向公安机关移交152人次。市公安局表示,接下来希望推动整合公安机关、医疗卫生系统掌握的号贩子信息,建立统一数据库,完善“黑名单”。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1755136, encodeId=ca941e5513664, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Sun Jun 10 08:48:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298435, encodeId=48ba129843560, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513224, encodeId=ee27151322461, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591308, encodeId=7a68159130881, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625717, encodeId=a3181625e17c5, content=<a href='/topic/show?id=b12d38e172c' target=_blank style='color:#2F92EE;'>#号贩子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38717, encryptionId=b12d38e172c, topicName=号贩子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d2020837807, createdName=zhangjiqing, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1755136, encodeId=ca941e5513664, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Sun Jun 10 08:48:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298435, encodeId=48ba129843560, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513224, encodeId=ee27151322461, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591308, encodeId=7a68159130881, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625717, encodeId=a3181625e17c5, content=<a href='/topic/show?id=b12d38e172c' target=_blank style='color:#2F92EE;'>#号贩子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38717, encryptionId=b12d38e172c, topicName=号贩子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d2020837807, createdName=zhangjiqing, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1755136, encodeId=ca941e5513664, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Sun Jun 10 08:48:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298435, encodeId=48ba129843560, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513224, encodeId=ee27151322461, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591308, encodeId=7a68159130881, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625717, encodeId=a3181625e17c5, content=<a href='/topic/show?id=b12d38e172c' target=_blank style='color:#2F92EE;'>#号贩子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38717, encryptionId=b12d38e172c, topicName=号贩子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d2020837807, createdName=zhangjiqing, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1755136, encodeId=ca941e5513664, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Sun Jun 10 08:48:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298435, encodeId=48ba129843560, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513224, encodeId=ee27151322461, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591308, encodeId=7a68159130881, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625717, encodeId=a3181625e17c5, content=<a href='/topic/show?id=b12d38e172c' target=_blank style='color:#2F92EE;'>#号贩子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38717, encryptionId=b12d38e172c, topicName=号贩子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d2020837807, createdName=zhangjiqing, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
    2018-01-21 chendoc248
  5. [GetPortalCommentsPageByObjectIdResponse(id=1755136, encodeId=ca941e5513664, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Sun Jun 10 08:48:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298435, encodeId=48ba129843560, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513224, encodeId=ee27151322461, content=<a href='/topic/show?id=b9df56361aa' target=_blank style='color:#2F92EE;'>#挂号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56361, encryptionId=b9df56361aa, topicName=挂号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86c910536361, createdName=ms55066533437992, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591308, encodeId=7a68159130881, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625717, encodeId=a3181625e17c5, content=<a href='/topic/show?id=b12d38e172c' target=_blank style='color:#2F92EE;'>#号贩子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38717, encryptionId=b12d38e172c, topicName=号贩子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d2020837807, createdName=zhangjiqing, createdTime=Sun Jan 21 14:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]

相关资讯

2017年北京医院价格投诉降四成

医疗服务价格投诉大降,而背后原因正是北京市医改过程中推行的医疗行业服务留痕。

北京医院多学科联动为社区居民送“获得感”

12 月 24 日,数九寒天,冷风嗖嗖,北京市朝阳区高碑店北花园社区卫生服务站内却热闹非凡,人头攒动。北京医院 9 位慢性病学专家在内分泌科郭立新主任带领下,利用周日时间下基层, 开展防治糖尿病及其并发症多学科义诊工作, 为社区居民送去温暖和健康。

北京全面统一城乡医保

12月13日,北京市政府召开新闻发布会,发布《北京市城乡居民基本医疗保险办法》。《办法》明确,自2018年1月1日起实施统一的城乡居民医疗保险制度。北京城乡居民医保不再区分城镇和农村户籍,覆盖所有未参加城镇职工基本医疗保险的户籍城乡居民,包括老年人、劳动年龄内居民和学生儿童。北京市户籍人员的外埠户籍配偶、子女,没有其他基本医疗保障的也可参加本市城乡居民医保。

北京诊疗手术费将适时提价

《北京市“十三五”期间深化医药卫生体制改革实施方案》正式对外发布,确定北京医改六大方面23项重点实施任务。其中,备受老百姓关注的医疗价格改革下一步还将有所动作。方案提出,将适时提高诊疗、手术、康复、护理、中医等医疗服务项目价格,降低大型医用设备检查、检验项目价格以及药品、耗材价格和费用。诊疗、手术、中医费将适时提高老百姓最为关心的是医疗价格问题。此次实施方案明确,政府定价范围将逐渐缩小,基本医疗服

北京各大医院启动“神药”监控,每家不少于15个品种

近段时间,清退“神药”的风暴正在席卷全国,北京各大医院(三级医院)也正行动动。近日,北京市卫生计生委向各区县卫计委、属地各三级医院印发《关于加强医疗机构重点监控药品管理的通知》(以下简称通知),《通知》明确,将非治疗必须、临床疗效证据不充分的药品列为“重点监控药品”,各医疗机构要建立相关目录,连续3个月进入医疗机构销售前20位的重点监控药品,将采取限用或停用等措施。据北京市卫计委相关负责人介绍

北京紧急配送4万盒抗流感药

流感高发季,用于抗流感病毒的奥司他韦成为医疗机构的热门药物。日前部分医疗机构出现了奥司他韦短缺的情况,北京青年报记者从市食药监局了解到,本周已启动紧急调配,各批发企业已经将4万盒奥司他韦供应到医疗机构,可满足用药需求,昨日又有4000盒奥司他韦运达北京。